TGF-β type 2 receptor–mediated modulation of the IL-36 family can be therapeutically targeted in osteoarthritis

MLA

Li, Tieshi, et al. “TGF-β Type 2 Receptor–mediated Modulation of the IL-36 Family Can Be Therapeutically Targeted in Osteoarthritis.” Science Translational Medicine, vol. 11, no. 491, May 2019. EBSCOhost, https://doi.org/10.1126/scitranslmed.aan2585.

APA

Li, T., Chubinskaya, S., Esposito, A., Jin, X., Tagliafierro, L., Loeser, R., Hakimiyan, A. A., Longobardi, L., Ozkan, H., & Spagnoli, A. (2019). TGF-β type 2 receptor–mediated modulation of the IL-36 family can be therapeutically targeted in osteoarthritis. Science Translational Medicine, 11(491). https://doi.org/10.1126/scitranslmed.aan2585

Chicago

Li, Tieshi, Susan Chubinskaya, Alessandra Esposito, Xin Jin, Lidia Tagliafierro, Richard Loeser, Arnavaz A. Hakimiyan, Lara Longobardi, Huseyin Ozkan, and Anna Spagnoli. 2019. “TGF-β Type 2 Receptor–mediated Modulation of the IL-36 Family Can Be Therapeutically Targeted in Osteoarthritis.” Science Translational Medicine 11 (491). doi:10.1126/scitranslmed.aan2585.